Acumen Pharmaceuticals, Inc.
For the period ended Dec 31, 2025. Filed Apr 23, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Dec 31, 2025 · Filed Apr 23, 2026
ABOS$0.22+4.5%Stored close · as of Nov 6, 2026
Contents
APPENDIX A -i-
APPENDIX A
ACUMEN PHARMACEUTICALS, INC.
AMENDED AND RESTATED 2021 EQUITY INCENTIVE PLAN
Adopted by the Board of Directors: April 21, 2026
Approved by the Stockholders: [ ], 2026
TABLE OF CONTENTS
Page
| 1. GENERAL. | 1 |
|---|---|
| 2. SHARES SUBJECT TO THE PLAN. | 1 |
| 3. ELIGIBILITY AND LIMITATIONS. | 2 |
| 4. OPTIONS AND STOCK APPRECIATION RIGHTS. | 3 |
| 5. AWARDS OTHER THAN OPTIONS AND STOCK APPRECIATION RIGHTS. | 6 |
| 6. ADJUSTMENTS UPON CHANGES IN COMMON STOCK; OTHER CORPORATE EVENTS. | 7 |
| 7. ADMINISTRATION. | 9 |
| 8. TAX WITHHOLDING. | 11 |
| 9. MISCELLANEOUS. | 11 |
| 10. COVENANTS OF THE COMPANY. | 14 |
| 11. ADDITIONAL RULES FOR AWARDS SUBJECT TO SECTION 409A. | 14 |
| 12. SEVERABILITY. | 17 |
| 13. TERMINATION OF THE PLAN. | 17 |
| 14. DEFINITIONS. | 17 |
-i-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.